Online Program

Physician champions and clinical performance reports: Informing policy with race-specific findings on equity in cancer treatment outcomes

Wednesday, November 4, 2015

Samuel Cykert, MD, Division of General Medicine and Clinical Epidemiology and NC Area Health Education Centers Program, University of North Carolina Chapel Hill, Chapel Hill, NC
Dwight Heron, MD, FACRO, FACR, University of Pittsburgh/ UPMC CancerCenter
Brian Cass, Cecil G. Sheps Center for Health Services Research, UNC-CH, Chapel Hill, NC
Steven Evans, MD, Pittsburgh Surgical Specialists, Inc, University of Pittsburgh
Michael Davis, UPMC CancerCenter
Ziya Gizlice, PhD, Center for Health Promotion and Disease Prevention, University of North Carolina Chapel Hill, Chapel Hill, NC
Matthew Manning, MD, Radiation Oncology, Cone Cancer Center, Greensboro, NC
Christina Hardy, MPH, Center for Health Promotion and Disease Prevention, University of North Carolina Gillings School of Public Health, Chapel Hill, NC
Skip Hislop, Cone Health Regional Cancer Center, Greensboro, NC
Linda Barry Robertson, DrPH, RN, MSN, Dept of Medicine/Hem Onc, University of Pittsburgh, Pittsburgh, PA
Jennifer Schaal, MD, The Partnership Project, Greensboro, NC
The Accountability for Cancer Care through Undoing Racism and Equity study is a partnership between communities and health systems to optimize transparency and accountability to achieve racial equity in cancer treatment among patients with early stage breast and lung cancer. The interventions designed to achieve these goals include development of a real time warning system fed by electronic health record data to signal patients’ missed appointments or delayed milestones in expected cancer care, health equity training for cancer center staff, a special navigator exposed to potential barriers to care through the lens of undoing racism training, and regular feedback sessions for cancer center clinicians using local race-specific treatment data. Note that as a baseline, 5 years of retrospective data were obtained at each cancer center. Two measures are being used to gauge the effect of the interventions: (1) completion of expected care of those patients enrolled in the real time registry system, and (2) ongoing, de-identified whole population data for early stage breast and lung cancer patients treated by the participating cancer centers. Feedback of both measures are being used in the clinician sessions. We will describe the role of the physician champion as a leader toward health equity and report on the early outcomes of patients enrolled in the warning system, the time trends of the whole population data relative to the retrospective data. We will also highlight some qualitative aspects of the feedback discussions and explain potential policy implications of this approach for cancer care and chronic disease.

Learning Areas:

Chronic disease management and prevention
Clinical medicine applied in public health
Provision of health care to the public

Learning Objectives:
Describe how data feedback can be used to address cancer disparities. Identify the role of a physician champion in the feedback process Assess other possible policy implications of transparent feedbackin cancer and other chronic disease management

Keyword(s): African American, Health Disparities/Inequities

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I'm the co-principal investigator for the ACCURE Study, an NCI funded interventional trial to reduce treatment disaprities in breast and lung cancer. I also lead other trials in this area and have published and spoken in the area many times.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.